Related Experiment Video
Updated: Dec 14, 2025
10:13
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
16.9K
Molecular Interaction Between Butorphanol and κ-Opioid Receptor
Jiafu Ji1,2, Wenzhen Lin2,3, Amey Vrudhula2
1From the Department of Anesthesiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Anesthesia and Analgesia
|July 24, 2020
Summary
Butorphanol exhibits higher affinity for the kappa-opioid receptor (KOR) than the mu-opioid receptor (MOR). This study reveals butorphanol
Area of Science:
- Pharmacology
- Molecular Biology
- Neuroscience
Background:
- Opioid misuse is linked to poor understanding of opioid-receptor interactions.
- The kappa-opioid receptor (KOR) is crucial for pain and addiction.
- Butorphanol, an analgesic, has unique properties and lower addiction potential.
Purpose of the Study:
- Investigate butorphanol's interaction with KOR.
- Elucidate molecular mechanisms of butorphanol-KOR binding.
- Provide insights for safer opioid analgesic use.
Main Methods:
- Naltrexone competition assay to determine binding affinity.
- G-protein and beta-arrestin activation assays using cell lines.
- KOR internalization studies in Neuro2A cells.
- In silico molecular docking of butorphanol to KOR.
Main Results:
- Butorphanol shows high affinity for KOR (Kd 0.1 nM), significantly higher than for MOR.
- Butorphanol acts as a partial agonist for KOR G-protein activation but a full agonist for beta-arrestin recruitment.
- Molecular docking indicates butorphanol binds to a key KOR cavity.
Conclusions:
- Butorphanol is a partial KOR agonist via G-protein and a full agonist via beta-arrestin pathways.
- Structural insights explain butorphanol's unique KOR interaction and activation.
- Findings contribute to understanding opioid pharmacology and safer analgesic development.
More Related Videos
Related Concept Videos
01:22Opioid Receptors: Overview
3.5K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.5K
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
773
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
773
01:25Analgesia and Pain Management
1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
01:28Drug-Receptor Interaction: Antagonist
4.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
4.5K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
664
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
664
01:25Drug-Receptor Interaction: Agonist
3.6K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.6K